Esophageal Carcinoma — Trials

Esophageal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

807 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 307
Recruiting: 179
Ph III recruiting: 26
Growth YoY: +33.8%
Industry share: 21%
Top sponsor: Fudan University
Termination share: 26.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (62)

clinicaltrialsPublishedShowing 451–500 of 807 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06190639	A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC	recruiting	Phase 2	31	Zhejiang Cancer HospitalOTHER	1	Jan 5, 2024	clinicaltrials
NCT06190847	Oral Microbiome is Associated With the Response to Chemoradiotherapy in Initial Inoperable Patients With Esophageal Squamous Cell Cancer	unknown	—	97	Anhui Provincial HospitalOTHER_GOV	1	Jan 5, 2024	clinicaltrials